Here, there was significant differences between high and low expressions of GDI2 in HCC patients with clinical index as weight (P = 0.035), BMI (P = 0.020) and AFP (ng/ml) (P = 0.019). This evidence concerns the gene AFP and hepatocellular carcinoma.